Seltene vaskuläre Erkrankungen der Netzhaut – Teil 1

Zusammenfassung

Neben der diabetischen Retinopathie und den arteriellen und venösen Verschlusserkrankungen existiert eine Reihe weiterer Ursachen für vaskuläre Netzhauterkrankungen, deren Früherkennung für die Differenzialdiagnose und Therapie bedeutsam sind. Diese Übersicht stellt wichtige generalisierte oder periphere vaskuläre Netzhauterkrankungen vor. Der zweite Teil fasst vaskuläre Netzhauterkrankungen mit vorwiegend makulärer Symptomatik zusammen.

Abstract

This review provides an overview of retinal vascular disorders that are less frequent in Germany and Europe compared to diabetic retinopathy and retinal venous or arterial occlusive disorders. The knowledge of these disorders is important for the differential diagnosis of retinal vascular disorders as well as potentially associated systemic disorders. In the current part one epidemiology, pathophysiology, clinical presentation, and therapy are discussed for hypertensive retinochoroidopathy, ocular ischemic syndrome, retinal alterations in sickle cell disease, Eales disease, radiation retinopathy, peripheral exudative hemorrhagic chorioretinopathy, and retinal disorders associated with pregnancy.

Schlüsselwörter

Hypertensive Retinopathie - okuläres Ischämiesyndrom - Sichelzellretinopathie - Morbus Eales - schwangerschaftsinduzierte Chorioretinopathie

Key words

Hypertensive retinopathy - ocular ischemic syndrome - sickle cell retinopathy - Eales disease - pregnancy-induced chorioretinopathy

• Literatur

• 1 Barth T, Helbig H. [Diabetic Macular Edema]. Klin Monbl Augenheilkd 2021; 238: 1029-1043
• 2 Barth T, Helbig H. [Diabetic retinopathy]. Klin Monbl Augenheilkd 2021; 238: 1143-1159
• 3 Lang GE, Lang SJ. [Retinal Vein Occlusions]. Klin Monbl Augenheilkd 2018; 235: 1297-1315
• 4 Lang GE, Lang SJ. [Retinal Artery Occlusions]. Klin Monbl Augenheilkd 2018; 235: 109-120
• 5 Di Marco E, Aiello F, Lombardo M. et al. A literature review of hypertensive retinopathy: systemic correlations and new technologies. Eur Rev Med Pharmacol Sci 2022; 26: 6424-6443
• 6 Dziedziak J, Zaleska-Zmijewska A, Szaflik JP. et al. Impact of arterial hypertension on the eye: A review of the pathogenesis, diagnostic methods, and treatment of hypertensive retinopathy. Med Sci Monit 2022; 28: e935135
• 7 Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004; 351: 2310-2317
• 8 Badawi SAQ, Takruri M, Albadawi Y. et al. Four severity levels for grading the tortuosity of a retinal fundus image. J Imaging 2022; 8: 258
• 9 Van Rysselberge C, Balikova I, Judice L. et al. Multimodal imaging in Hellp-related chorioretinopathy. Retin Cases Brief Rep 2022; 16: 333-337
• 10 Nam KY, Lee MW, Jun JH. et al. Different characteristics of retinal damage between chronic hypertension and hypertensive retinopathy. Sci Rep 2022; 12: 18902
• 11 Liu Y, Li J, Pan J. et al. Morphological changes in and quantitative analysis of macular retinal microvasculature by optical coherence tomography angiography in hypertensive retinopathy. Hypertens Res 2021; 44: 325-336
• 12 Li J, Zhang W, Zhao L. et al. Positive correlation between hypertensive retinopathy and albuminuria in hypertensive adults. BMC Ophthalmol 2023; 23: 66
• 13 Kim YH, Sung MS, Park SW. Clinical features of ocular ischemic syndrome and risk factors for neovascular glaucoma. Korean J Ophthalmol 2017; 31: 343-350
• 14 Lee D, Tomita Y, Yang L. et al. Ocular ischemic syndrome and its related experimental models. Int J Mol Sci 2022; 23
• 15 Saito K, Akiyama H, Mukai R. Alteration of optical coherence tomography angiography in a patient with ocular ischemic syndrome. Retin Cases Brief Rep 2021; 15: 588-592
• 16 Wang H, Wang Y, Li H. Multimodality imaging assessment of ocular ischemic syndrome. J Ophthalmol 2017; 2017: 4169135
• 17 Abdelkader A, Shaaban M, Zahran MM. et al. The impact of optical coherence tomography in the early identification of children with sickle cell retinopathy. Int J Clin Pract 2022; 2022: 9131423
• 18 Zulueta P, Minniti CP, Rai A. et al. Routine ophthalmological examination rates in adults with sickle cell disease are low and must be improved. Int J Environ Res Public Health 2023; 20
• 19 Pinhas A, Zhou DB, Otero-Marquez O. et al. Efficacy of CRISPR-based gene editing in a sickle cell disease patient as measured through the eye. Case Rep Hematol 2022; 2022: 6079631
• 20 Nithianandan H, Sridhar J. Surgical and medical perioperative management of sickle cell retinopathy: A literature review. Int Ophthalmol Clin 2020; 60: 77-87
• 21 Murillo Lopez S, Medina Medina S, Murillo Lopez F. Ealesʼ disease: epidemiology, diagnostic and therapeutic concepts. Int J Retina Vitreous 2022; 8: 3
• 22 Majumder PD, Sitaula RK, Biswas J. Pediatric Eales disease: An Indian tertiary eye center experience. J Pediatr Ophthalmol Strabismus 2018; 55: 270-274
• 23 Biswas J, Reesha KR, Pal B. et al. Long-term outcomes of a large cohort of patients with Ealesʼ disease. Ocul Immunol Inflamm 2018; 26: 870-876
• 24 Fallico M, Chronopoulos A, Schutz JS. et al. Treatment of radiation maculopathy and radiation-induced macular edema: A systematic review. Surv Ophthalmol 2021; 66: 441-460
• 25 Zemba M, Dumitrescu OM, Gheorghe AG. et al. Ocular complications of radiotherapy in uveal melanoma. Cancers (Basel) 2023; 15: 333
• 26 Binkley EM, Tamplin MR, Vitale AH. et al. Longitudinal optical coherence tomography angiography (OCT-A) in a patient with radiation retinopathy following plaque brachytherapy for uveal melanoma. Am J Ophthalmol Case Rep 2022; 26: 101508
• 27 Seibel I, Vollhardt D, Riechardt AI. et al. Influence of ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet) – a prospective randomized controlled trial. Graefes Arch Clin Exp Ophthalmol 2020; 258: 869-878
• 28 Shroff D, Sharma M, Chhablani J. et al. Peripheral exudative hemorrhagic chorioretinopathy-a new addition to the spectrum of pachychoroid disease?. Retina 2021; 41: 1518-1525
• 29 Safir M, Zloto O, Fabian ID. et al. Peripheral exudative hemorrhagic chorioretinopathy with and without treatment-clinical and multimodal imaging characteristics and prognosis. PloS One 2022; 17: e0275163
• 30 Zicarelli F, Preziosa C, Staurenghi G. et al. Peripheral exudative haemorrhagic chorioretinopathy: a widefield imaging study. Br J Ophthalmol 2021; 105: 1410-1414
• 31 Jurgens L, Yaici R, Schnitzler CM. et al. Retinal vascular occlusion in pregnancy: three case reports and a review of the literature. J Med Case Rep 2022; 16: 167
• 32 Sharon Y, Adler A, Tiosano A. et al. The effect of pregnancy on the course of uveitis in single and multiple pregnancies. Graefes Arch Clin Exp Ophthalmol 2023; 261: 803-808
• 33 Ersoz MG, Arf S, Hocaoglu M. et al. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol 2019; 103: 725-729
• 34 Kim JW, Park MH, Kim YJ. et al. Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia. Eye (Lond) 2016; 30: 349-354
• 35 Zhao X, Li R, Huang D. et al. Decreased retinal thickness in preschool offspring of maternal gestational hypertension: the Nanjing Eye Study. Acta Ophthalmol 2020; 98: e674-e679
• 36 Widyaputri F, Rogers SL, Kandasamy R. et al. Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis. JAMA Ophthalmol 2022; 140: 486-494